FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Bid/Ask 01:54:14 2024-05-20 pm EDT | ||
| 14.41 EUR | +10.08% |
|
| Current month | +46.75% | ||
| 1 month | +283.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-20 | 14.41 | +10.08% |
| 24-05-17 | 13.09 | -27.88% |
| 24-05-16 | 18.15 | +41.80% |
| 24-05-15 | 12.8 | -0.31% |
| 24-05-14 | 12.84 | +4.14% |
Delayed Quote Börse Stuttgart
Last update May 20, 2024 at 01:54 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462V |
| ISIN | DE000HD462V7 |
| Date issued | 2024-03-27 |
| Strike | 207.7 $ |
| Maturity | Unlimited |
| Parity | 1.77 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.15 € |
|---|---|
| Lowest since issue | 2.94 € |
| Spread | 0.18 € |
| Spread % | 1.23% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6
USD
Average target price
285.9
USD
Spread / Average Target
+24.01%
- Stock Market
- Certificates
- Certificat
